Si, X., Strappe, P., Blanchard, C
[DOI] [PubMed] [Google Scholar] 38.Barrington P, Chien JY, Showalter HD, Schneck K, Cui S, Tibaldi F, et al
That's not therapy, that's an experiment
n = the number of patients remaining in the respective study arm at each time point Longer-Term Efficacy The efficacy of ABILIFY MAINTENA in maintaining symptomatic control in schizophrenia was established in a double-blind, placebo-controlled, randomized-withdrawal trial in adult patients (Study 2) who met DSM-IV-TR criteria for schizophrenia and who were being treated with at least one antipsychotic medication
Obese mice that had a TMAO-producing enzyme (FMO3) conferred protection against obesity (109)
Modulatory role of HMG-CoA reductase inhibitors and ezetimibe on LDL-AGEs-induced ROS generation and RAGE-associated signalling in HEK-293 cells